On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
With ValGenesis VLMS, change control driven validation activities are reduced from weeks to mere hours, and the company gains faster access to detailed metrics that help reduce costs and cycle time
The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance
Subscribe To Our Newsletter & Stay Updated
